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INTRODUCTION
The vertebrate heart is formed as a simple linear tube in which
myocardium and endocardium are separated by a cell-free layer of
extracellular matrix (ECM) termed the cardiac jelly. Shortly after the
onset of heart looping, local differentiation pathways are activated,
initiating the formation of the atrial and ventricular chambers that are
separated by a discrete domain known as the atrioventricular (AV)
canal. The signaling pathways that underlie these processes are
highly conserved across species ranging from zebrafish to human
(Stainier, 2001; Beis et al., 2005; Srivastava, 2006). However, the
mechanism by which the differentiation of the AV segment in the
primary heart tube is controlled remains largely unknown, although
some molecular circuits of the regulatory hierarchy, such as Notch
and Tbx2/Bmp2, have been implicated in previous studies.
In zebrafish, heart looping starts at ~36 hours post-fertilization
(hpf). The chambers express distinct myosin genes [vmhc, amhc
(myh6 – Zebrafish Information Network) (Yelon, 2001; Berdougo
et al., 2003)] whereas the expression of myocardial genes [e.g.
bmp4, cspg2 (vcana – Zebrafish Information Network) (Walsh and
Stainier, 2001), fibulin 1 (Zang et al., 1997)] and endocardial genes
[e.g. notch1b (Walsh and Stainier, 2001), has2 (Smith et al., 2009)]
becomes restricted to the AV boundary. In addition, AV endocardial
cells differentiate into cuboidal cells that express Alcam (Alcama,
DM-GRASP) (Beis et al., 2005). The differentiated AV endocardial
and myocardial cells produce increased amounts of ECM
components resulting in cardiac jelly swelling, which initiates valve
formation (Moorman and Christoffels, 2003).
Defects in cardiac valves are the most common type of
congenital malformation (Loffredo, 2000). Thus, it is important to
identify novel regulators of cardiac valve development. Utilizing a
microarray-based temporal RNA expression data set describing
heart development, we identified the gene nephronectin (npnt) as
transiently expressed in the heart at the time of valve initiation and
formation. Npnt has previously been identified as a ligand of
integrin 81 (Brandenberger et al., 2001; Sato et al., 2009). It
contains an N-terminal signal peptide followed by EGF-like
repeats, an RGD sequence and a C-terminal MAM domain, but it
does not contain a transmembrane domain. Thus, Npnt has been
classified as an ECM protein (Brandenberger et al., 2001). Recent
data have shown that Npnt is required for the invasion of the
metanephric mesenchyme by the ureteric bud during kidney
development (Linton et al., 2007). Furthermore, it has been
associated with malignant melanoma. Npnt overexpression in
melanoma cell lines increased cell adhesion and decreased cell
migration (Kuphal et al., 2008). In addition, overexpression of
Npnt in mouse MC3T3-E1 cells promoted their differentiation into
osteoblasts, an effect mediated via the EGF-like repeats (Fang et
al., 2010; Kahai et al., 2010). However, to our knowledge, Npnt
expression has not thus far been associated with heart development
and its function remains poorly characterized.
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SUMMARY
The extracellular matrix is crucial for organogenesis. It is a complex and dynamic component that regulates cell behavior by
modulating the activity, bioavailability and presentation of growth factors to cell surface receptors. Here, we determined the role
of the extracellular matrix protein Nephronectin (Npnt) in heart development using the zebrafish model system. The vertebrate
heart is formed as a linear tube in which myocardium and endocardium are separated by a layer of extracellular matrix termed
the cardiac jelly. During heart development, the cardiac jelly swells at the atrioventricular (AV) canal, which precedes valve
formation. Here, we show that Npnt expression correlates with this process. Morpholino-mediated knockdown of Npnt prevents
proper valve leaflet formation and trabeculation and results in greater than 85% lethality at 7 days post-fertilization. The earliest
observed phenotype is an extended tube-like structure at the AV boundary. In addition, the expression of myocardial genes
involved in cardiac valve formation (cspg2, fibulin 1, tbx2b, bmp4) is expanded and endocardial cells along the extended tube-like
structure exhibit characteristics of AV cells (has2, notch1b and Alcam expression, cuboidal cell shape). Inhibition of has2 in npnt
morphants rescues the endocardial, but not the myocardial, expansion. By contrast, reduction of BMP signaling in npnt
morphants reduces the ectopic expression of myocardial and endocardial AV markers. Taken together, our results identify Npnt as
a novel upstream regulator of Bmp4-Has2 signaling that plays a crucial role in AV canal differentiation.
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Here, we identify Npnt as a novel regulator of heart
development. Our data show that Npnt is an upstream regulator of
Bmp4-Has2 signaling and that it is critically involved in AV canal
differentiation during zebrafish heart development.
MATERIALS AND METHODS
Zebrafish maintenance
Wild-type AB and transgenic Tg(myl7:EGFP-HsHRAS)s883 (D’Amico et
al., 2007), Tg(kdrl:EGFP)s843 (Jin et al., 2005), Tg(–5.1myl7:nDsRed2)f2
(Mably et al., 2003) and Tg(TOP:GFP)w25 (Dorsky et al., 2002) zebrafish
(Danio rerio) were maintained at 28°C as described (Westerfield, 1993).
Microarray data
Total RNA of rat cardiac ventricles from different developmental stages
[embryonic day (E) 11 to postnatal day (P) 10.5] at 12-hour intervals was
isolated using Trizol (Invitrogen). For each time point, the RNA was
extracted from 6-122 pooled hearts after removal of the atria. In addition,
three independent RNA samples were generated for E11, E15, E19 and P2.
Expression analysis was performed using the Affymetrix GeneChip RAT
230 Expression Set. Preprocessing of the data, i.e. background subtraction,
normalization and probeset summarization, were performed according to
the robust multi-array average (RMA) procedure.
Reverse transcriptase PCR (RT-PCR)
RNA was extracted from 30 or more zebrafish embryos at the indicated
developmental stages, adult zebrafish tail fin or rat heart ventricles (E11 to
E20, n≥10; P5, P10 and adult, n≥3) using Trizol (Invitrogen). RT-PCR was
performed following standard protocols. Primers (5 to 3) for rat were:
Gapdh, CAGAAGACTGTGGATGGCCC and AGTGTAGCCCAG  -
GATGCCCT;  Npnt total, CACAGTGCAAACACGGAGAG and
GCATCAGCATGTATCCGTTG;  Npnt variants, CTGGGGACAGTG  -
TCAACCTT and GCATCAGCATGTATCCGTTG. Primers for zebrafish
were:  gapdh, TGGGTGTCAACCATGAGAAA and AACCTGGT  -
GCTCCGTGTATC;  npnt F1, CATTCGGGAGCTTCAAGTGT; F2,
ATGTGGATCATAAAGTTCATGTTGA; F3, CAATGGTCTGTGTCGG  -
TACG; R, CTGAAGGTCAAAGCCGTCAT; R2, TGTCATTATGGG  -
GTATTGTGTGA; and R3, TCATCCTACCGCACTCTGTTG.
In situ hybridization
At 24 hpf, 0.2 mM 1-phenyl-2-thiourea was used to prevent pigmentation.
Embryos were fixed in 4% paraformaldehyde (PFA) in PBS for 2 hours at
room temperature (RT), washed twice (0.1% Tween 20 in PBS, 4°C),
dehydrated and processed for in situ hybridization utilizing digoxigenin-
labeled RNA probes against: vmhc (Yelon, 2001), amhc (Berdougo et al.,
2003), cspg2, notch1b, bmp4 (Walsh and Stainier, 2001), fibulin 1 (Zang
et al., 1997), tbx2b (Smith et al., 2009), has2 (Bakkers et al., 2004), gfp,
npnt and zgc:172265 (NM_001114911.1), which is named in this study
itga8 owing to its homology to itga8 of other species (UniGene Cluster
UGID:2630752) (see Fig. S9 in the supplementary material). For in situ
probes against npnt and itga8 mRNA, 517 bp (npnt, 5-CAATGGTC -
TGTGTCGGTACG-3 and 5-CTGAAGGTCAAAGCCGTCAT-3) 
and 713 bp (itga8, 5-GAAAAGCCCACGGTTTACAA-3   and 5-
TCCCCTGTGAACTCTCCAAC-3) fragments were amplified from
cDNA and cloned into the pGEM-T Easy vector (Promega) to create
pGEMTeasy-Znpnt and pGEMTeasy-itga8. Whole-mount embedded
embryos (17% gelatine in PBS) were fixed with 4% PFA in PBS (overnight
at RT), sectioned (120 mm) and mounted (Kaiser’s glycerol gelatin,
Merck). For thin sections (Leica RM2255), embryos were embedded in
paraffin (npnt,4   mm) or epoxy resin (bmp4, 2 mm).
Cloning of zebrafish npnt and microinjection
A 1945 bp fragment of zebrafish npnt cDNA (NM_001145580) was
amplified with TopTaq DNA polymerase (Qiagen) using RNA derived
from 52 hpf embryos and primers 5-CACCATGTGGATCATA -
AAGTTCATGTTGA-3 and 5-TCATCCTACCGCACTCTGTTG-3,
purified, cloned (pGEM-T Easy), subcloned into pCS2+ after EcoRI
digestion (pCS2+-Fnpnt) and sequenced. Capped npnt mRNA was
generated after linearization (pCS2+-Fnpnt, SacII) using the mMESSAGE
mMACHINE SP6 In Vitro Transcription Kit (Ambion). One-cell stage
embryos were injected into the yolk (≤4 nl; PV820 Injector, World
Precision Instruments) with morpholinos (npnt MO1, 5-
CATGAACTTTATGATCCACATCTCC-3; npnt MO2, 5-TGTGAAAC -
GGCAGACGGAACTCACT-3; npnt MO3, 5-GAATAGGCTAAG -
TGCCGTCTCACCT-3; has2 MO, 5-AGCAGCTCTTTGGAGATGTC -
CCGTT-3; Gene Tools) and/or capped npnt mRNA in 0.1 M KCl. Control
injection was with 0.05% Phenol Red (Sigma).
Wnt signaling and BMP signaling inhibition
Wnt signaling inhibition was achieved by overexpressing Dkk1 using
Tg(hsp70l:dkk1-GFP)w32. MO2- or control-injected Tg(hsp70l:dkk1-
GFP)w32 embryos were raised at 28°C and heat shocked at 37°C for 30
minutes at 36 hpf or 40 hpf. Cardiac morphology was analyzed at 52 hpf
using bright-field microscopy. Dorsomorphin (Tocris) dissolved in water
was used to inhibit BMP signaling (Yu et al., 2008) and was added at 
10mm at 25 hpf in E3 medium.
Western blot
Protein was isolated from 60 embryos at 2 days post-fertilization (dpf).
Yolk was removed by shearing (pipetting), shaking twice for 3 minutes
each at 1100 rpm in deyolking buffer (55 mM NaCl, 1.8 mM KCl, 1.25
mM NaHCO3) and washing in 110 mM NaCl, 3.5 mM KCl, 2.7 mM
CaCl2, 10 mM Tris-HCl (pH 8.5). Embryos were pelleted (300 g, 1 minute,
4°C) and lysed by sonication (four pulses of 5 seconds each) in lysis buffer
[Cell Signaling buffer plus protease inhibitor mix (Roche) and 1 mM
PMSF (Sigma)]. After centrifugation (17,000 g, 5 minutes, 4°C)
supernatants were resolved in NuPAGE Novex Bis-Tris Gels (Invitrogen),
blotted and analyzed with anti-Npnt (1:300, Cosmo Bio), anti-p-Smad1/5/8
(1:1000, Cell Signaling), anti-acetylated tubulin (1:1000, Sigma) or anti-
pan-Actin (Cell Signaling, 1:1000) antibody.
Immunohistochemistry and histological analysis
Immunohistochemistry was performed as described (Dong et al., 2007).
Samples were incubated with anti-Alcam (zn8) (1:10, DSHB) or s46 (1:10,
DSHB) antibody, DsRed antibody (1:200, Clontech) and subsequently labeled
with Alexa-conjugated secondary antibodies (Molecular Probes). Staining
with anti-p-Smad1/5/8 antibody (1:200, Cell Signaling) was performed with
minor modifications: fixation in 2% PFA in PBS for 1.5 hours at RT; blocking
in 10% goat serum/0.3% Triton X-100 in PBS. For F-actin staining, samples
were incubated with Rhodamine-labeled phalloidin (1:75, Invitrogen) for 1
hour at RT in PBDT (0.1% DMSO, 0.1% Triton X-100 in PBS). For
localization of hyaluronan, 4 mm paraffin sections were treated with 3% H2O2
for 10 minutes at RT and then incubated with biotinylated HA-binding protein
(bHABP, Calbiochem, 5 mg/ml, diluted in 50 mM Tris, 150 mM NaCl, pH
7.4) at 4°C overnight. After washing, sections were incubated with HRP-
conjugated avidin followed by incubation with 3,3-diaminobenzidine
peroxidase substrate (Vector Laboratories) and counterstaining with
Hematoxylin (AppliChem). The specificity of staining was tested by treating
sections with 100 U hyaluronidase (Sigma) for 30 minutes at 37°C prior to
incubation with bHABP.
Morphological analysis, confocal and transmission electron
microscopy (TEM)
For Nomarski (Zeiss) and confocal microscopy, tricane-anesthetized
embryos were mounted in 1% low-melting-point agarose in E3 medium.
Confocal sections (1.3 mm) covering the entire heart were imaged on a
Zeiss LSM710 and images were processed to obtain projections (LSM
Image Browser, Zeiss). For TEM, embryos were fixed by immersion in
1.5% glutaraldehyde/1.5% paraformaldehyde in 0.15 M HEPES buffer (pH
7.3) for at least 24 hours. The specimens were subsequently osmicated,
stained en bloc with uranyl acetate, dehydrated in an ascending ethanol
series and embedded in epoxy resin. Ultrathin sections from comparable
regions of the heart were generated and analyzed using a Zeiss TEM 902.
Live imaging
Movies of embryos embedded in 1% low-melting-point agarose in E3
medium under a Leica DM6000 B microscope were recorded with a Sony
HDR-SR12 camcorder and formatted (Wondershare or iSkysoft video
converter).
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Data are expressed as the mean ± s.e.m. of at least three independent
experiments. Statistical significance of differences was evaluated by one-
way ANOVA followed by Bonferroni’s post-hoc test (GraphPad Prism).
P<0.05 was considered statistically significant.
RESULTS
npnt is transiently expressed during heart
development
Based on a large-scale temporal RNA expression analysis we
have identified nephronectin (Npnt) as transiently expressed in
the rat heart at the time of valve initiation and formation (Fig.
1A) (Okagawa et al., 1996). These results were confirmed by
RT-PCR for both known variants of rat Npnt using independent
sets of mRNA (Fig. 1B). To determine the expression pattern of
npnt in zebrafish, we performed whole-mount in situ
hybridization analyses. At 24 hpf, npnt is markedly expressed at
the tail bud, head, in the posterior part of the gut and in the
pharyngeal endoderm (Fig. 1C,D). At 34 hpf, highest expression
was observed in the pronephric region, with persistent
expression in the head (Fig. 1E,F). npnt expression in the heart
was first detected at 44 hpf (Fig. 1G,H). Thin sections
demonstrated that npnt is expressed in the myocardium
throughout the heart (Fig. 1I,J). Cardiac npnt expression was still
observed at 48 hpf, but was undetectable at 53 hpf when npnt
expression was most prominent in the pharynx, esophagus and
the pharyngeal endoderm (Fig. 1K,L). Taken together, our data
demonstrate that npnt  is transiently expressed during heart
development.
Npnt knockdown disrupts heart development and
is lethal
To assess the role of Npnt in zebrafish heart development we
applied antisense morpholino oligonucleotides. We designed one
translation-inhibitory morpholino (MO1) and two splicing-
inhibitory morpholinos that target the splice donor site of exon E5
(MO2) or exon E1 (MO3) (Fig. 2A, see Fig. S1A in the
supplementary material). Our data indicate that both MO2 and
MO3 were effective in disrupting correct splicing of npnt pre-
mRNA, resulting in a marked decrease of mature npnt mRNA (Fig.
2B,C, see Fig. S1B in the supplementary material). RT-PCR
analyses demonstrated that MO2 injection resulted in intron
insertion (Fig. 2B) and exon E5 deletion, which was confirmed by
sequencing (Fig. 2C). Western blot analysis demonstrated that
injection of MO1 (3.5 pmol), MO2 (1.4 pmol) and MO3 (2.4 pmol)
resulted in a marked decrease in the Npnt protein level (Fig. 2D,
see Fig. S1C in the supplementary material). Therefore, all
subsequent studies were performed using these amounts of
morpholinos. Collectively, our results demonstrate that injection of
MO1, MO2 and MO3 efficiently knocked down the expression of
Npnt on the mRNA and/or protein level.
To determine the effect of Npnt knockdown on heart
development we injected morpholinos into the embryos of
Tg(myl7:EGFP-HsHRAS)s883 transgenic zebrafish (n>200, four
independent experiments), in which GFP is localized at the
cardiomyocyte plasma membrane, facilitating live imaging of heart
morphology. MO1, MO2 or MO3 injection did not show any
obvious effect on zebrafish development until 40 hpf. However,
Npnt knockdown resulted in 89±7.9% (mean ± s.e.m.) lethality at
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Fig. 1. npnt is transiently expressed during rat and zebrafish heart development. (A) Npnt expression levels in rat heart tissue from E11 to
P10.5 in 12-hour intervals according to microarray analysis (Affymetrix GeneChip Rat Expression Set 230). Blue line, real profile; red line,
smoothened profile. (B) RT-PCR analysis of Npnt mRNA expression during rat heart development. Gapdh was used as loading control. Ladder
indicates a size marker. (C-L) Zebrafish npnt expression determined by whole-mount in situ hybridization. (C) Lateral view of a 24 hpf embryo
showing npnt expression at tailbud (white arrowhead), head (black arrow) and posterior part of the gut (white arrow). (D) Dorsal view of the
anterior part of the trunk demonstrating expression in pharyngeal endoderm (arrows). (E,F) Lateral (E) and dorsal (F) views at 34 hpf showing
expression in the pronephric region (arrows) and head (arrowhead). (G,H) Ventrolateral view (G) and parasagittal section (H) at 44 hpf
demonstrating npnt expression in heart (arrows) and jaw (arrowheads). (I,J) Paraffin section (4 mm) confirming expression in the myocardium 
(I, 200; J, 1000). (K) Dorsal view showing npnt expression at 53 hpf in pharynx, esophagus (arrow) and pharyngeal endoderm (arrowheads).
(L) Transverse section through the trunk confirming expression in the endodermal cells of the anterior gut (arrow). A, atrium; EC, endocardium; MC,
myocardium; V, ventricle. Scale bars: 100 mm in C-H,K,L; 50 mm in I; 20 mm in J.
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7 dpf (Fig. 2E). The first obvious phenotype was pericardial edema
at 75 hpf, indicating a cardiac defect (Fig. 2F, see Fig. S1D in the
supplementary material). A closer analysis of morphant hearts
revealed that valve formation and trabeculation at 110 hpf were
perturbed in 86±3.9%, with more than 30% of those lacking of
valve leaflets as well as trabeculation (Fig. 2G-I). The morphants
are also characterized by cardiac jelly swelling throughout the heart
(Fig. 2I). Live imaging revealed no obvious differences between
wild type and morphants in cardiac function and circulation at 36
hpf and 52 hpf (see Movies 1-4 in the supplementary material).
Taken together, our data indicate that npnt is essential for cardiac
development in zebrafish.
npnt morphant hearts have an extended AV canal
To determine the earliest heart phenotype we utilized 
transgenic zebrafish lines Tg(myl7:EGFP-HsHRAS)s883 and
Tg(–5.1myl7:nDsRed2)f2, which express RFP in cardiomyocyte
nuclei. Npnt depletion induced formation of an extended tube-like
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Fig. 2. Npnt knockdown disrupts heart development and is lethal. (A) Scheme of the effect of npnt splice-inhibitory morpholino MO2. Exons
are represented by boxes and introns by lines. Dotted lines indicate the region targeted by MO1 or MO2 and arrows indicate RT-PCR primer
positions. Exon E3 could not be detected. (B,C) RT-PCR analysis of mRNAs from control and MO2-injected zebrafish embryos at 52 hpf using npnt
primers as indicated in A and gapdh primers (loading control) (n3). MO2 inhibited npnt pre-mRNA splicing, resulting in intron insertion (B) and
exon E5 deletion (C). (D) Western blot analysis of control and MO1- or MO2-injected embryos at 52 hpf (n3). Both morpholinos efficiently
knocked down the Npnt protein level. (E) Npnt knockdown resulted in 89±7.9% (mean ± s.e.m.) lethality at 7 dpf. (F) Lateral view of control, MO1-
or MO2-injected embryos at 75 hpf. MO1 or MO2 injection resulted in pericardial edema (arrowheads). (G) Quantitative analysis. Valve formation
and trabeculation are perturbed in 86±3.9% (mean ± s.e.m.) of morphant hearts at 110 hpf. (H) Confocal images of hearts from control and MO2-
injected embryos from transgenic Tg(myl7:EGFP-HsHRAS)s883 zebrafish at 80 hpf suggesting that the initiation of trabeculation is perturbed in npnt
morphants. Red arrows indicate trabeculae. (I) Hematoxylin and Eosin (H&E)-stained sagittal sections of hearts from control and MO2-injected
embryos at 110 hpf. In contrast to morphants, control embryos develop proper atrioventricular (AV) valve leaflets (white oval). Black arrowheads
indicate the AV boundary; green arrows indicate expanded cardiac jelly. A, atrium; V, ventricle; PC, pericardium. Scale bars: 500 mm in F; 50 mm in
H,I.
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hearts from non-injected or Phenol Red-injected embryos (n>200,
four independent experiments) (Fig. 3A-D, see Fig. S1E in the
supplementary material). Based on the severity of the cardiac defect
at 52 hpf, morphants were categorized into three classes: type I, mild
AV canal extension; type II, obvious AV canal extension; type III,
straight heart (see Fig. S2A in the supplementary material). MO1
injection caused heart defects in 71±4.0% of embryos (type I,
29±2.6%; type II, 54±5.3%; type III, 17±8.3%) and MO2 injection
in 86±4.4% of embryos (type I, 21±3.2%; type II, 56±4.0%; type III,
23±3.9%) (see Fig. S2B,C in the supplementary material). All three
morpholinos resulted in Npnt knockdown and in similar phenotypes,
suggesting that the observed phenotypes are a functional
consequence of Npnt depletion.
To prove that the observed AV canal phenotype is specific to
Npnt depletion we performed rescue experiments by co-injecting
capped npnt mRNA and MO2. Note that MO2, as a splice-
inhibitory morpholino, does not affect the translation of injected
npnt mRNA. Sequencing indicated that all cloned npnt cDNAs
lacked exon E3 (51 bp) and a part of exon E13 and contained an
additional exon E14, as compared with the npnt sequence
published by NCBI (see Fig. S3 in the supplementary material).
RT-PCR analyses of cDNA derived from zebrafish embryos at
different developmental stages confirmed that this is the major
splice variant (see Fig. S4A,B in the supplementary material). In
adult zebrafish tail fin tissue only, we detected a second variant (see
Fig. S4B in the supplementary material). Sequencing analysis
demonstrated that this variant contains exon E3 but lacks part of
exon E13. A Motif Scan analysis revealed no change in the overall
domain structure of the proteins encoded by the two variants (see
Fig. S4C,D in the supplementary material).
Assuming that the cloned cDNA represents the npnt mRNA at
52 hpf, we used linearized pCS2+-Fnpnt plasmid as template to
generate capped npnt mRNA. Injection of 50 pg capped npnt
mRNA rescued the AV extension in a subset of MO2-injected
embryos (Fig. 3E,F) and had only a minor effect on cardiac
development when injected alone (88±1.5% normal hearts; Fig.
3F). Importantly, 40±2.3% of embryos had normal hearts after co-
injection of npnt mRNA and MO2 as compared with 11±2.0% after
MO2 injection alone (Fig. 3F). In addition, injection of 50 pg
capped npnt mRNA markedly reduced the severity of the AV canal
defect in the remaining embryos, with defective hearts showing an
increase in type I defects (from 23.6±1.2% to 48.7±2.4%) and a
decrease in type II defects (from 60±1.1% to 26.5±2.6%) (Fig. 3G).
The slight increase in the type III phenotype (from 16.4±2.4% to
24.8±2.4%) might be due to npnt overexpression. In summary, the
rescue experiments confirm that the MO-mediated phenotypes are
due to Npnt depletion.
To characterize the extended tube-like structure at the AV
boundary we performed Alcam staining of embryos from the
transgenic zebrafish line Tg(kdrl:EGFP)s843, in which GFP is
expressed in all endothelial cells. At 52 hpf, all cardiomyocytes and
endocardial cells at the AV boundary express Alcam. The AV canal
in wild-type animals is 5-6 tiers long at the superior AV boundary
(SAV) and 3-4 tiers long at the inferior AV boundary (IAV) of
Alcam-positive endocardial cells (Fig. 4A). In npnt morphants, the
AV canal was extended by 84.4±27.6% (8-12 tiers, SAV) or
85.0±22.5% (5-7 tiers, IAV) (Fig. 4B,C). In accordance with these
data, endocardial expression of notch1b was also expanded in npnt
morphant hearts at the AV boundary as compared with control
hearts (Fig. 4D). These data suggest that Npnt knockdown causes
an increase in the number of AV endocardial cells and thus an
expansion of endocardial AV specification.
In contrast to the AV endocardium, there is no AV myocardium-
specific marker available. Therefore, we used genes as markers
whose expression becomes restricted during development to the
AV myocardium: cspg2 (Versican), fibulin 1 and bmp4 (Zang et al.,
1997; Walsh and Stainier, 2001); bmp4 is also expressed at the
outflow and inflow tract (Fig. 4E-G) (Walsh and Stainier, 2001).
Compared with control hearts, expression of cspg2, fibulin 1 and
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Fig. 3. Npnt knockdown causes extension of the AV canal. (A-D) Projections of confocal images of hearts from control (A,C) and MO2-injected
(B,D) embryos from transgenic Tg(myl7:EGFP-HsHRAS)s883 (A,B) and Tg(–5.1myl7:nDsRed2)f2 (C,D) zebrafish at 52 hpf, suggesting an extension of
the AV canal (brackets) in npnt morphants. (E) Representative images of hearts from control, MO2-injected and MO2 + npnt mRNA-injected
embryos from transgenic Tg(myl7:EGFP-HsHRAS)s883 zebrafish at 52 hpf. Brackets indicate the AV boundary. (F) Quantitative analysis (n>160 from
three independent experiments; mean ± s.e.m.). Note that injection of npnt mRNA rescued the MO2-mediated AV canal extension. (G) Quantitative
analysis scoring of type I (mild extension of the AV canal), type II (obvious extension of the AV canal) and type III (straight heart) AV canal defects
(mean ± s.e.m.). A, atrium; V, ventricle. Scale bars: 50 mm.
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bmp4 was expanded in npnt morphant hearts at 52 hpf (Fig. 4E-G).
In addition, ectopic expression of cspg2 was detected at the inflow
tract (Fig. 4E). By contrast, chamber-specific expression of the
cardiac marker genes vmhc and amhc (Yelon et al., 1999) appeared
normal (Fig. 4H). Our data suggest that the extended tube-like
structure represents, on a molecular level, an extended AV canal.
However, owing to the lack of an AV myocardium-specific marker
it remains unclear whether Npnt regulates myocardial in addition
to endocardial AV specification.
To determine the origin of the additional myocardial AV canal-
like cells we performed cell count experiments with double-
transgenic animals [Tg(–5.1myl7:nDsRed2)f2  Tg(myl7:EGFP-
HsHRAS)s883]. The overall number of cardiomyocytes (chambers
+ AV boundary) was not significantly different between control and
morphant hearts (Fig. 4I,J). These data support the assumption that
the AV boundary extension is not due to an increase in
cardiomyocyte number, but rather to differentiation into AV canal-
like cells at the expense of chamber cells.
Npnt knockdown causes cardiac jelly expansion
and increases has2 expression
One characteristic of AV cells is increased expression of ECM
components at the onset of looping. Signaling between
myocardium and endocardium is essential for heart development,
including valve formation (Armstrong and Bischoff, 2004; Hsieh
et al., 2006; Holtzman et al., 2007). In addition, it has been
suggested that an increase in cardiac jelly can interfere with this
signaling and perturb heart development (Shirai et al., 2009). To
determine whether the extended AV canal produces normal
amounts of cardiac jelly we used Tg(kdrl:EGFP)s843 embryos,
counterstained with Rhodamine-phalloidin (which detects F-actin)
to visualize the myocardium. Analysis of confocal sections of
hearts from control and npnt morphant hearts at 52 hpf showed that
the space between endocardium and myocardium is markedly
increased in morphants (Fig. 5A,B), suggesting that Npnt
knockdown causes cardiac jelly expansion.
A major constituent of cardiac jelly is glycosaminoglycan
hyaluronan (HA), which is synthesized by the product of hyaluronan
synthase 2 (has2), a downstream target of Tbx2 (Shirai et al., 2009).
Both has2 and tbx2 are regulated by BMP signaling (Camenisch et
al., 2000; Gaussin et al., 2002; Shirai et al., 2009). In wild-type
zebrafish, the expression of both genes is restricted to the AV
boundary at 2 dpf (Walsh and Stainier, 2001; Hurlstone et al., 2003;
Chi et al., 2008) (Fig. 5C,E). By contrast, expression of has2 and
tbx2b was expanded in npnt morphants (Fig. 5D,F). Importantly, our
data demonstrate that the phenotype was also rescued on a molecular
(bmp4, cspg2) and cellular (Alcam) (see Fig. S5 in the supplementary
material) level in morphologically rescued npnt morphants.
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Fig. 4. Characterization of the extended AV canal. (A,B) Confocal sections of whole-mount Alcam-stained (red, indicating myocardium and
differentiated endocardial cells) control (A) and MO2-injected (B) embryos from transgenic Tg(kdrl:EGFP)s843 zebrafish at 52 hpf. Npnt depletion
caused an increase in differentiated endocardial cells (cuboidal in shape, Alcam positive and EGFP positive) at the AV boundary. Arrowheads indicate
the AV boundary; red line, myocardium; green, endocardial cells; black dots, Alcam-positive endocardial cells. (C) Quantitative analysis of Alcam-
positive endocardial cells (mean ± s.e.m.). SAV, superior AV; IAV, inferior AV. (D-G) Sections of 52 hpf control and MO2-injected embryos after
whole-mount in situ hybridization for notch1b (D), cspg2 (E), fibulin 1 (F) and bmp4 (G). Expression of these genes was expanded in npnt
morphants (brackets). (H) In situ hybridization with probes against the chamber-specific marker genes amhc and vmhc. (I) Projections of confocal
images of hearts from whole-mount control and MO2-injected embryos from double-transgenic [Tg(–5.1myl7:nDsRed2)f2  Tg(myl7:EGFP-
HsHRAS)s883] zebrafish stained for atrial myosin heavy chain (MHC, white) and DsRed (red). Yellow line, AV junction. (J) Quantitative analysis of total
(chambers + AV boundary) and atrial cardiomyocyte number (mean ± s.e.m.). ns, not significant. A, atrium; V, ventricle. Scale bars: 50 mm.
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HA staining and transmission electron microscopy (TEM) analyses.
The specificity of HA staining was tested using hyaluronidase (see
Fig. S6 in the supplementary material). Npnt knockdown increased
the amount of HA in the cardiac jelly compared with wild-type
embryos (Fig. 5G,H). Has2 knockdown caused a marked reduction
of HA in the cardiac jelly, both in npnt morphants (Fig. 5I) and in
wild-type embryos (Fig. 5J). In addition, TEM analyses revealed
that the density of cardiac jelly in wild type and npnt morphants is
comparable (Fig. 5K,L) and that the junctional complexes
(comprising adherens and tight junctions) in the endocardium in
npnt morphants are still intact, suggesting that the expanded cardiac
jelly is not due to increased permeability of the endocardium (Fig.
5M,N). These results show that Npnt is an inhibitory upstream
regulator of bmp4, tbx2b and has2 expression and thus regulates
the composition of the cardiac jelly. At 40 hpf, before npnt
expression, bmp4 expression was restricted to the AV canal in both
wild-type embryos and npnt  morphants (see Fig. S7A in the
supplementary material). This indicates that Npnt is required to
maintain the restricted expression of AV canal markers.
Has2 knockdown rescues the npnt morphant
endocardial phenotype
has2 plays an essential role during valve formation (Camenisch et
al., 2000). An effect on the number of AV canal cells has not been
reported. To determine whether expanded expression of has2
caused the increased number of AV endocardial cells we performed
Has2 knockdown experiments. One-cell stage embryos were
injected with has2 and npnt morpholinos and analyzed for AV
endocardial (Alcam and notch1b) and myocardial (cspg2, bmp4)
specific gene expression at 52 hpf (Fig. 6). Has2 knockdown in
npnt morphants reduced the number of Alcam-positive AV
endocardial cells from 180.8±21.9% (8-11 tiers, SAV) or
188.2±33.5% (5-8 tiers, IAV) to 30.8±10.5% (1-2 tiers, SAV) or
11.0±16.1% (0-1 tier, IAV) compared with wild-type embryos (Fig.
6A,B). Has2 knockdown in wild-type embryos resulted in a
reduction from 100±8.6% (5-6 tiers, SAV) or 100±16.1% (3-4 tiers,
IAV) to 25.1±16.1% (0-2 tiers, SAV) or 5.9±13.2% (0-1 tier, IAV)
(Fig. 6A,B). In addition, Has2 knockdown rescued the expansion
of notch1b (Fig. 6C). These data demonstrate that has2 is required
for prevalvular endocardial cell differentiation. Taken together, our
data show that the increased number of AV endocardial cells in
npnt morphants is due to the expanded expression of has2.
To assess whether expanded expression of has2 caused the
myocardial phenotype, we determined the expression of cspg2
and bmp4 after Has2 knockdown in control and npnt morphant
embryos. The expression of these genes in npnt morphants as
well as in control embryos either remained unchanged or was
upregulated after Has2 knockdown (Fig. 6C). These data indicate
that ectopic endocardial cell differentiation, but not the
myocardial phenotype, in npnt morphants is due to ectopic
expression of has2.
Inhibition of BMP signaling reduces AV canal
expansion
Bmp4 is a major regulator for cardiac valve formation (Wessels
and Markwald, 2000; Jiao et al., 2003). However, there is a
debate as to whether Bmp4 is an upstream regulator of has2
expression. Using explant cultures it has been shown that
inhibition of BMP signaling does not affect has2 expression
(Klewer et al., 2006). By contrast, tbx2 overexpression studies
suggested that has2 expression is controlled by BMP-Smad
signaling during cushion formation (Shirai et al., 2009). To
determine whether BMP signaling acts downstream of Npnt we
inhibited BMP signaling in npnt morphants with dorsomorphin,
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Fig. 5. Npnt knockdown causes cardiac jelly expansion and
expanded expression of has2 and tbx2b. (A,B) Confocal sections
from whole-mount F-actin-stained (red) control (A) and MO2-injected
(B) Tg(kdrl:EGFP)s843 zebrafish embryos at 52 hpf. The space between
endocardium and myocardium was increased at the AV boundary
(arrowheads) and throughout the chambers (red asterisks) in npnt
morphants. (C-F) Sections of 52 hpf control and MO2-injected embryos
after whole-mount in situ hybridization for has2 and tbx2b expression
(brackets). Note that the expression of these genes is expanded in npnt
morphants. (G-J) Sections (4 mm) of control, MO2-, has2 MO-, or has2
MO + MO2-injected zebrafish embryos at 52 hpf stained for
hyaluronan (brown) and counterstained with Hematoxylin (blue). 
(K-N) Transmission electron microscopy of hearts (K,L) and endocardial
cells (M,N) from control and MO2-injected embryos at 52 hpf.
Arrowheads indicate junctional complexes. A, atrium; BC, blood cell;
CJ, cardiac jelly; EC, endocardium; MC, myocardium; V, ventricle. Scale
bars: 50 mm in A-F; 10 mm in G-J; 5 mm in K,L; 1 mm in M,N.
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a chemical antagonist of BMP receptors (Yu et al., 2008), at 25
hpf (see Fig. S7B,C in the supplementary material), and analyzed
the embryos at 52 hpf.
Dorsomorphin treatment in npnt morphants reduced the
number of Alcam-positive AV endocardial cells from
163.6±18.2% (8-10 tiers, SAV) or 176.8.2±17.3% (5-8 tiers,
IAV) to 127.3±12.9% (6-8 tiers, SAV) or 107.4±17.3% (3-4 tiers,
IAV) compared with wild-type embryos (Fig. 7A,B) and rescued
the expanded expression of notch1b (Fig. 7C). In wild-type
embryos, inhibition of BMP signaling had no effect on the
number of Alcam-positive cells (see Fig. S7D in the
supplementary material) or upon notch1b expression (see Fig.
S7E in the supplementary material).
To assess whether ectopic expression of has2 and cspg2 is
dependent on BMP signaling, we performed in situ hybridization
analyses on 52 hpf dorsomorphin-treated npnt morphants and wild-
type embryos. Dorsomorphin partially rescued the expanded
expression of has2 and cspg2 at the AV region in npnt morphants
and abolished ectopic expression of cspg2 in the inflow tract (Fig.
7C). Expression in wild-type embryos was unaffected (see Fig. S7E
in the supplementary material).
To better understand Bmp4-Smad1/5/8 signaling in the AV canal
of zebrafish we analyzed the cellular origin of bmp4 expression and
Smad1/5/8 phosphorylation at 52 hpf. Thin sections of wild-type
and npnt morphant hearts demonstrated that bmp4 is expressed in
the myocardium of the AV canal (see Fig. S7F in the
supplementary material). Phosphorylated Smad1/5/8 (p-Smad1/5/8)
could be detected in the myocardium and at very low levels in the
endocardium (see Fig. S7G,H in the supplementary material). This
suggests that myocardial Bmp4 can diffuse in a controlled manner
to the AV endocardium, activating p-Smad1/5/8 signaling. By
contrast, the level of p-Smad1/5/8 was increased in the expanded
AV endocardium of npnt morphants to similar levels as in the
myocardium (see Fig. S7G,H in the supplementary material).
Thus, our data indicate that knockdown of Npnt causes
expanded expression of bmp4, which is mainly responsible for the
phenotype of npnt morphants, and suggest that BMP signaling is
an upstream regulator of has2 and cspg2 in zebrafish heart (Fig.
7D). Based on our data, we suggest two models. First, Npnt binds
to a receptor that is expressed in the chamber myocardium and that
this mediates the repression of bmp4 expression (Fig. 7D, model
1). Second, Npnt regulates the diffusion of Bmp4, preventing
paracrine signaling towards the endocardium and the chambers
(Fig. 7D, model 2).
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Fig. 6. Has2 knockdown rescues the endocardial phenotype in
npnt morphants. (A) Confocal sections and schematics of whole-
mount Alcam-stained (red, indicating myocardium and differentiated
endocardial cells) MO2-injected, has2 MO + MO2-injected, control-
injected and has2 MO-injected embryos from transgenic
Tg(kdrl:EGFP)s843 zebrafish at 52 hpf. Red line, myocardium; green,
endocardial cells; black dots, Alcam-positive endocardial cells. Npnt
depletion caused an increase in differentiated AV endocardial cells
(cuboidal in shape, Alcam positive and EGFP positive) (number of tiers
≥8, SAV; number of tiers ≥5, IAV). Knockdown of Has2 in npnt
morphants or wild-type embryos reduced the number of tiers to two or
fewer in SAV or IAV. Arrowheads indicate the AV boundary.
(B) Quantitative analysis. Has2 knockdown in npnt morphants rescued
the AV canal endocardium extension (mean ± s.e.m.). SAV, superior AV;
IAV, inferior AV. (C) Bright-field images of 52 hpf MO2-injected and
has2 MO + MO2-injected embryos after whole-mount in situ
hybridization for notch1b, cspg2 and bmp4 expression (brackets). Note
that Has2 knockdown reduced the expanded expression of notch1b
but not of cspg2 or bmp4 in npnt morphants (arrows). A, atrium; V,
ventricle. Scale bars: 50 mm.
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Our data identify Npnt as a novel regulator of early heart
development. Several lines of evidence support this conclusion.
First, Npnt knockdown causes 89±7.9% lethality. Second, npnt
morphant hearts were characterized by an expanded AV canal,
increased cardiac jelly, impaired trabeculation and a failure of
proper AV valve formation. Third, Has2 knockdown rescued the
endocardial phenotype in npnt morphants. Fourth, chemical
inhibition of BMP signaling rescued AV canal extension in npnt
morphants. In summary, our data indicate that Npnt regulates the
differentiation of the AV segment via Bmp4-Has2 signaling.
It has been shown that regionally specific interactions of
myocardium and endocardium are required to initiate the
formation of prevalvular mesenchyme (Krug et al., 1985;
Mjaatvedt et al., 1987; Wagner and Siddiqui, 2007). Changes in
the composition or amount of the ECM can interfere with valve
formation. Knockdown of Cspg2 or Has2 results in reduced
amounts of cardiac jelly (Mjaatvedt et al., 1998; Camenisch et
al., 2000) and in a failure of endocardial cushion formation. By
contrast, knockdown of the ECM protein Npnt caused an
increase in cardiac jelly. Moreover, it resulted in an extended AV
canal on the morphological, cellular and molecular level. This
suggests that Npnt does not simply act as a structural protein but
functions as a negative regulator of genes involved in AV canal
differentiation.
Our data indicate that Npnt is required to maintain the restricted
expression of Bmp4 and that expanded bmp4 expression in npnt
morphants causes increased expression of cspg2 and has2, which
explains the increase in cardiac jelly. has2 plays an essential role
in the formation of cardiac jelly and in the transformation of
epithelium to mesenchyme (Camenisch et al., 2000). Has2
knockdown in npnt morphants rescued the endocardial phenotype
and demonstrates that Npnt controls AV endocardial cell
differentiation by regulating has2 expression. Has2 knockdown in
npnt morphants, however, did not rescue the ectopic expression of
bmp4 or cspg2. Thus, it appears that Bmp4 is an upstream regulator
of  has2 expression and that the endocardial phenotype is a
consequence of ectopic myocardial bmp4 expression.
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Fig. 7. Inhibition of BMP signaling reduces AV canal expansion. (A) Projections of confocal images and confocal sections of hearts of MO2-
injected Tg(kdrl:EGFP)s843 zebrafish embryos at 52 hpf with and without dorsomorphin treatment stained for Alcam (red, indicating myocardium
and differentiated endocardial cells). (B) Quantitative analysis. Inhibition of BMP signaling by dorsomorphin (Dorso) in the npnt morphants rescued
the AV canal endocardium extension (mean ± s.e.m.). SAV, superior AV; IAV, inferior AV. (C) Bright-field images of 52 hpf untreated and
dorsomorphin-treated npnt morphants after whole-mount in situ hybridization for notch1b, cspg2 and has2 expression. Dorsomorphin treatment
reduced the expression of notch1b and has2 at the AV boundary in npnt morphants (brackets). Moreover, ectopic expression of cspg2 at the inflow
tract in npnt morphants is abolished (arrowheads) and cspg2 expression at the AV boundary is partially rescued. (D) Model of the regulatory role of
Npnt. 1 and 2 are two possible mechanisms of how Npnt affects Bmp4 signaling. (1) Npnt activates a receptor that is expressed in the chamber
myocardium to repress Bmp4 signaling. (2) Npnt inhibits diffusion of Bmp4, resulting in autocrine signaling. Arrows indicate changes after Npnt
depletion in wild type (red) or upon has2 depletion (blue) or dorsomorphin treatment (green) in npnt morphants. Red dashed arrow indicates Bmp4
diffusion in the npnt morphant. Black dashed arrow indicates controlled Bmp4 diffusion in the wild type. A, atrium; V, ventricle; EC, endocardium;
MC, myocardium; MO, morpholino. Scale bars: 50 mm.
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BMP signaling has been shown to regulate has2 expression
(Shirai et al., 2009), although the data are controversial (Klewer et
al., 2006). Inhibition of BMP signaling in npnt morphants fully
rescued the endocardial phenotype, partially rescued the AV canal
extension and reduced the expression of has2 and cspg2. In wild-
type embryos, dorsomorphin did not affect the basal expression of
AV canal marker genes. This might be due to the fact that
dorsomorphin treatment resulted in only partial inhibition of BMP-
Smad signaling and that complete inhibition could not be achieved
even at higher dorsomorphin concentrations (see Fig. S7B,C in the
supplementary material). Another possible explanation is that
endogenous BMP signaling is redundant at the AV canal. Taken
together, our data suggest that Npnt is an upstream regulator of
BMP signaling. Moreover, these findings indicate that ectopic
BMP signaling regulates has2 and cspg2 expression.
It has been suggested that AV endocardial differentiation is
mediated through Wnt/-catenin signaling. npnt morphants show
many similarities to zebrafish apc mutants, in which the Wnt
signaling pathway is constitutively activated (Hurlstone et al.,
2003). Hearts of both appear normal at 36 hpf but subsequently
form excessive cardiac jelly. In apc mutants, Wnt/-catenin
signaling is active throughout the heart, resulting in expanded has2
expression from the AV canal throughout the heart at 72 hpf
(Hurlstone et al., 2003). However, our analyses indicate that Npnt
knockdown does not result in ectopic activation of Wnt/-catenin
signaling at 52 hpf (see Fig. S8 in the supplementary material).
Our data have identified Npnt as a crucial regulator of AV
canal differentiation and ECM composition by controlling Bmp4-
Has2 signaling. It will be important in the future to determine
how Npnt regulates BMP signaling. It is possible that chamber
myocardium expresses a receptor for Npnt that represses Bmp4
signaling (Fig. 7D, model 1). It has been shown that Npnt acts
during kidney development as a ligand of integrin 81,
regulating migration (Brandenberger et al., 2001; Sato et al.,
2009). However, during the time of npnt expression in the
zebrafish heart we did not detect integrin 8 (itga8) expression
in the heart by in situ hybridization, whereas strong expression
was detected in other tissues (see Fig. S9 in the supplementary
material). This indicates that Npnt does not signal through
integrin 8 during zebrafish heart development. Alternatively,
Npnt might activate growth factor receptor signaling. It has been
suggested that Npnt can induce signaling through its EGF-like
repeats, which are required for Npnt-induced osteoblast
differentiation (Kahai et al., 2010). Similarly, it has been
suggested that the EGF-like repeats of Versican can bind and
activate growth factor receptors (Wight, 2002). Thus, it will be
important to determine whether Npnt signals through a receptor
during heart development. Another possibility is that Npnt
modulates the bioavailability of Bmp4 (Fig. 7D, model 2). Npnt
might be required to establish an ECM in which Bmp4 can act
only in an autocrine fashion. Knockdown of Npnt might therefore
enable diffusion of Bmp4, and thus paracrine signaling, towards
the endocardium as well as the chambers (Fig. 7D, model 2).
Previously, it has been shown that mouse embryos lacking a
functional Npnt gene are born at the expected Mendelian frequency
but frequently display kidney agenesis or hypoplasia (Linton et al.,
2007). In addition, Npnt knockout mice exhibit a skin phenotype
(Fujiwara et al., 2011). The heart has thus far not been investigated.
The fact that the mouse Npnt knockout is not embryonic lethal
suggests that the regulation of Bmp4 signaling is more stringent in
mammals. This assumption is supported by the finding that the
Npnt family member Egfl6 is upregulated in Npnt knockout mice,
partially compensating for Npnt (Fujiwara et al., 2011).
In conclusion, Npnt acts as an inhibitor of Bmp4-Has2 signaling
to restrict AV canal differentiation and cardiac jelly swelling in
zebrafish. Interference with this pathway results in an expanded AV
canal, excessive cardiac jelly and a failure of valve formation.
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